IRYCIS
Miguel Moreno Molina is an experienced researcher and project manager with a focus on biomedicine and biosensor development. Currently serving as Investigador Adjunto at IRYCIS since September 2024, Miguel leads the Fortalece project. Previously, Miguel held the position of Drug Discovery and Preclinical Manager at aptaTargets, overseeing R&D processes and managing relationships with contract research organizations. As Chief Scientific Officer at Aptus Biotech, Miguel directed research and development projects centered on aptamer technology. Other roles include postdoctoral positions at Centro de Astrobiologia and the University of East Anglia, and technical leadership at BIOAPTER. Miguel holds a Doctorate in Biomedicine and a degree in Biology from Universidad de Alcalá.
This person is not in the org chart
This person is not in any teams
IRYCIS
IRYCIS was established in December 2009 via an agreement signed between the Ramón y Cajal University Hospital, the Universities of Alcalá, Complutense and Autónoma of Madrid, the Ministry of Health of the Community of Madrid and the Biomedical Research Foundation of the Ramón y Cajal University Hospital. IRYCIS received its accreditation from the Ministry of Science and Innovation in 2011, which was renewed in January 2017 by the Secretary of State for Research, Development and Innovation. In our name, at the heart of our acronym and in our logo, we are very proud to be following the path opened by Don Santiago Ramón y Cajal. We have created a common space where we can share ideas, projects and also researchers and teams, to ensure the convergence of scientific progress towards the challenges of our society.